KIT and gastrointestinal stromal tumor: GIST pathogenesis is most frequently attributed to gain-of-function mutations in the receptor tyrosine kinase KIT; however, activating mutations in platelet derived growth factor receptor-α (PDGFRA) have been observed in GISTs with wild-type KIT [1].